6:10 PM
 | 
Mar 22, 2010
 |  BC Extra  |  Clinical News

Calando reports CALAA-01 data

Calando Pharmaceuticals Inc. (Pasadena, Calif.) said intracellularly localized CALAA-01 was dose-dependently detected inside tumor biopsies following systemic delivery of the siRNA in three metastatic...

Read the full 110 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >